Central West Medicale Inc.

Central West Medicale Inc. CWMI is one of the industry's leading distributor of pharmaceutical products in the Philippines. Central West Medicale Inc.

Central West offers registered pharmaceutical products to cater the need of patients seeking for quality alternative healthcare. Central West Medicale Inc and its people do business with honesty and integrity. Extending our services to all healthcare partners and to Filipinos by providing access to global products at the best competitive price. Our people are trained to deliver excellent service a

t all times. We value the trust of our customers and we continue to strive to be the best in the industry. As healthcare being one of the most important part of life, we make sure that all our products are effective and conformed to all FDA requirements and laboratory tests. From our humble beginnings, CWMI is now present in almost private hospitals in the Visayas and Mindanao Regions. With the support of our distribution channels, our products are present in almost all parts of the Philippines region. has a wide variety of products in stock, all available to you. We guarantee all our products have been checked and passed all Government and laboratory required tests.

🚀URGENT HIRING! 🚀Are you ready to take the next step in your career this year 2025? We are looking for passionate and ta...
06/01/2025

🚀URGENT HIRING! 🚀

Are you ready to take the next step in your career this year 2025? We are looking for passionate and talented individuals to join our growing team!

✨ What We Offer:

-Competitive salary
-Growth opportunities
-Friendly and collaborative work environment

If you're ready for a new challenge, send your CV to jamcentralwest@gmail.com or generalsales@centralwestmed.com

👉 Apply now and become a part of our exciting journey!

STOP THE PAIN IN MINUTES ✋The game changer ANTACID ⚕️
30/11/2024

STOP THE PAIN IN MINUTES âś‹

The game changer ANTACID ⚕️

NOTICE TO THE PUBLIC‼️📢
07/11/2024

NOTICE TO THE PUBLIC‼️📢

🚀 We're Hiring! Join Our Team 🚀Are you ready to take the next step in your career? We are looking for passionate and tal...
18/10/2024

🚀 We're Hiring! Join Our Team 🚀

Are you ready to take the next step in your career? We are looking for passionate and talented individuals to join our growing team!

✨ What We Offer:

-Competitive salary
-Growth opportunities
-Friendly and collaborative work environment

If you're ready for a new challenge, send your CV to jamcentralwest@gmail.com or generalsales@centralwestmed.com

👉 Apply now and become a part of our exciting journey!

WE ARE HIRING 📢📢📢Send your updated CV now! 📩
27/09/2024

WE ARE HIRING 📢📢📢

Send your updated CV now! đź“©

⛨ FILGRASTIM⚕ FilgracentINDICATION:Fligrastim is a granulocyte colony-stimulating factor (G-CSF), a hasmatopoietic grow...
24/09/2024

⛨ FILGRASTIM
âš• Filgracent

INDICATION:
Fligrastim is a granulocyte colony-stimulating factor (G-CSF), a hasmatopoietic growth factor that stimulates the development of granulocytes. It is used to treat or prevent neutropenia in patients receiving myelosuppressive cancer chemotherapy and to reduce the period of neutroperia in patients undergoing bone marrow transplantation. It is also
used to moblue pencherd biood progentor cris tor use as an altemadve to bone marrow tar connon in he margotment of chror, neutroopne icoront, ordie, on idiopathic), and for persistent neutropenia in patients with adranced HIV infection.

DOSAGE AND ADMINISTRATION:
As an adjunct to antineoplastic therapy Filgrastim is given in a dose of 5 micrograms/kg daily starting not less than 24 hours after the last dose of antineoplastic. It can be given as single daily subcutaneous injection, as a continuous intravenous or subcutaneous infusion, or as a daily intravenous infusion over 15 to 30 minutes. Treatment is continued until the neutrophil count has stabilized within the normal range which may take up to 14 days or more. A formulation of Filgrastim conjugated with monomethoxy polyethylene glycol may also be used to reduce the incidence of neutropenia associated with antineoplastic therapy; it is given subcutaneous injection in a single dose of 6 mg, given not less than 24 hours after the last dose of antineoplastic.

Bone marrow transplantation
• The initial dose of Filgrastim following bone marrow transplantation is 10 micrograms/kg daily, adjusted according to response. This may be given intravenous infusion over 30 minutes or 4 hours, or by continuous intravenous or subcutaneous infusion over 24 hours.

For mobilization of peripheral blood progenitor cells
• A dose of 10 micrograms/kg daily of Filgrastim may be given subcutaneously as a single daily injection or by continuous infusion for 4 to 7 days until leucapheresis; if given after myelosuppressive chemotherapy, this dose is halved to 5 micrograms/kg daily by subcutaneous injection.

Patients with congenital neutropenia
• The initial dose is 12 micrograms/kg daily and in patients with idiopathic or cyclic neutropenia, the initial dose is 5 micrograms/kg daily. In these forms of neutropenia, the dose is given subcutaneously in single or divided doses and should be adjusted according to response.

Patients with HIV Infection and persistent neutropenia
•The initial dose is 1 microgram/kg daily by subcutaneous injection. The dose may be titrated up to a maximum of 4 micrograms/kg daily until a normal neutrophil count is achieved and then adjusted for maintenance according to response. Maintenance doses of 300 micrograms daily on 1 to 7 days a week have been used.

The Filgrastim doses described above for patients receiving antineoplastic therapy and for chronic neutropenias may also be given to children. Filgrastim should not be used in children or adolescents weighing less than 4 kg.

Dilution:
Filgrastim should not be diluted with saline solution for IV administration as the product will precipitate or as prescribed by the physician.

FORMULATION:
Each 0.5 mL pre-filed syringe cortains:
300 mog of Filgrastim concentrated solution Fhi. Eur (mG- OiSh) in aqueous bufle

Happy Birthday, Mama Mary! Today, we honor the Mother of us all, whose life was a testament of faith, humility, and unco...
08/09/2024

Happy Birthday, Mama Mary! Today, we honor the Mother of us all, whose life was a testament of faith, humility, and unconditional love. May her gentle presence continue to inspire and bless us always. 💙🙏

⛨ NOREPINEPHRINE⚕ NORECENT 10mgINDICATION:1. Secondary treatment of acute hypotension or shock according to different d...
28/08/2024

⛨ NOREPINEPHRINE
âš• NORECENT 10mg

INDICATION:
1. Secondary treatment of acute hypotension or shock according to different diseases (shock due to my myocardial infarction, and septicemia caused by shock, anaphylactic shock, hypotension or shock, according to the decreased circulating blood volume, acute hypotension during anesthesia, etc.)
2. Secondary treatment for cardiac arrest.

DOSAGE & ROUTE OF ADMINISTRATION:
1. Acute hypotension or shock
Properly increase or decrease by diluting Norepinephrine bitartrate 8mg (norepinephrine as 4mg) to 5% glucose injection liquid or 1000ml of 5% glucose saline injection while observing the reaction by intravenous infusion at a rate per minute of 2 ~ 3ml.
Individual differences may exist but the requirement for maintenance is 0.5ml to 1 ml per minute.
2. Cardiac Arrest
After retaining valid heart rate and ventilation while cardiac resuscitation, inject intravenously for case of acute hypotension or shock.

FORMULATION:
Each mL contains:
Norepinephrine (as bitartrate)....................2mg
(as 1mg Norepinephrine base)

⛨ NOREPINEPHRINE⚕ NORECENT 4mgINDICATION:1. Secondary treatment of acute hypotension or shock according to different di...
19/08/2024

⛨ NOREPINEPHRINE
âš• NORECENT 4mg

INDICATION:
1. Secondary treatment of acute hypotension or shock according to different diseases (shock due to my myocardial infarction, and septicemia caused by shock, anaphylactic shock, hypotension or shock, according to the decreased circulating blood volume, acute hypotension during anesthesia, etc.)
2. Secondary treatment for cardiac arrest.

DOSAGE & ROUTE OF ADMINISTRATION:
1. Acute hypotension or shock
Properly increase or decrease by diluting Norepinephrine bitartrate 8mg (norepinephrine as 4mg) to 5% glucose injection liquid or 1000ml of 5% glucose saline injection while observing the reaction by intravenous infusion at a rate per minute of 2 ~ 3ml.
Individual differences may exist but the requirement for maintenance is 0.5ml to 1 ml per minute.
2. Cardiac Arrest
After retaining valid heart rate and ventilation while cardiac resuscitation, inject intravenously for case of acute hypotension or shock.

FORMULATION:
Each mL contains:
Norepinephrine (as bitartrate)....................2mg
(as 1mg Norepinephrine base)

⛨ CEFEPIME⚕️CENTRAPIMEINDICATION:Cefepime powder for injection is indicated in the treatment of the following infections...
09/08/2024

⛨ CEFEPIME
⚕️CENTRAPIME

INDICATION:
Cefepime powder for injection is indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms:

Pneumonia (moderate to severe) caused by Streptococcus pneumonia, including cases associated with concurrent bacteremia, Pseudomonas aeruginosa, Klebsiella pneumonia, or Enterobacter species.

Empiric Therapy for Febrile Neutropenic Patients. Cefepime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. In patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation with hypotension at presentation with an underlying hematologic malignancy or with severe of prolonged neutropenia), antimicrobial monotherapy may not be appropriate. Insufficient data exist to support the efficacy of Cefepime monotherapy in such patients.

Uncomplicated and Complicated Urinary Tract Infections (including pyelonephritis) caused by Staphylococcus aureus (methicillin-susceptible strains only) or Streptococcus pyrogenes.

Uncomplicated Intra-abdominal infections (used in combination with Metronidazole) caused by Escherichia coli, Viridans Group Streptococci, Pseudomonas aeruginosa, Klebsiella pneumonia, Enterobacter species, or Bacteroides fragilis.

For Intravenous Use or Intramuscular Use
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefepime for injection and other antibacterial drugs, Cefepime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

FORMULATION
Each vial contains:
Cefepime Hydrochloride (equivalent to Cefepime), USP ………………..... 1g
(Sterile mixture of Cefepime hydrochloride and L-Arginine)

⛨ Cefoperazone + Sulbactam⚕️ Kephazon-SINDICATIONSMonotherapyCefoperazone + Sulbactam (Kephazon) is indicated for the tr...
01/08/2024

⛨ Cefoperazone + Sulbactam
⚕️ Kephazon-S

INDICATIONS
Monotherapy
Cefoperazone + Sulbactam (Kephazon) is indicated for the treatment of the following infections when caused by susceptible organisms :
• Respiratory Tract Infections (Upper and Lower)
• Urinary Tract Infections (Upper and Lower)
• Peritonitis, Cholecystitis, Cholangitis, and Other Intra-Abdominal Infections
Septicemia
Meningitis
• Skin andSoft Tissue Infections
Bone and Joint Infections
• Pelvic Inflammatory Disease, Endometritis, Gonorrhoea, and Other Infections of the Ge***al Tract.
Combination Therapy
Because of the broad spectrum of activity of Cefoperazone + Sulbactam (Kephazon) ,most infections can be treated adequately with this antibiotic alone. However, Cefoperazone + Sulbactam (Kephazon) may be used concomitantly with other antibiotics if such combinations are indicated. If an aminoglycoside is used, renal function should be monitored during the course of therapy.

DOSAGE AND ADMINISTRATION
The usual adult dose of Cefoperazone + Sulbactam (Kephazon-S) is 2 to 4 g per day (i.e. 1 to 2 g per day cefoperazone activity given intravenously or intramuscularly in equally divided doses every 12 hours.
In severe or refractory infections the daily dosage may be increased upto 8g Cefoperazone + Sulbactam (Kephazon) i.e., 4 g cefoperazone activity).
Patients receiving the 1:1 ratio may require additional cefoperazone administered separately. Doses should be administered every 12 hours in equally divided doses. The recommended maximum daily dosa ge of sulbactam. is 4g (8g of Cefoperazone + Sulbactam (Kephazon) Dosage regimens of Cefoperazone + Sulbactam (Kephazon) should be adjusted in patients with marked decrease in renal function (creatinine clearance of less than 30 ml/min) to compensate for the reduced clearance of sulbactam. Patients with creatinine clearances between 15 and 30 ml/min should receive a maximum of 1g of sulbactam administered every 12 hours (maximum daily dosage of 2g sulbactam), while patients with creatinine clearances of less than 15 ml/min should receive a maximum of 500 mg of sulbactam every 12 hours (maximum daily dosage of 1g sulbactam). In severe infections it may be necessary to administer additional cefoperazone separately.
The usual dosage of Cefoperazone + Sulbactam (Kephazon) in children is 40 to 80 mg/kg/day (i.e., 20-40 mg/kg/day cefoperazone activity) in 2 to 4 equally divided doses. In serious or refractory infections, these dosages may be increased up to 160 mg/kg/day of Cefoperazone + Sulbactam (Kephazon) (i.e., 80 mg/kg/day cefoperazone activity) in 2 to 4 equally divided doses. For neonates in the first week of life, the drug should be given every 12 hours. The maximum daily dosage of sulbactam in pediatrics should not exceed 80 mg/kg/day (160 mg/kg/day). Cefoperazone + Sulbactam (Kephazon) In cases where doses above 80 mg/kg/day of cefoperazone activity are necessary, additional cefoperazone should be administered separately.

Intravenous Administration
For intermittent infusion each vial of Cefoperazone + Sulbactam (Kephazon) should be reconstituted with the appropriate amount (shown in table) of 5% dextrose in Water, 0.9% Sodium Chloride or Sterile Water for Injection and then diluted to 20 ml with the same solution followed by administration over 15 to 60 minutes. For intravenous injection, each vial should be reconstituted as above and administered over a minimum of three minutes.

Intramuscular Administration
Lidocaine HCL 2% in a suitable vehicle for IM administration. However, not for initial reconstitution.

FORMULATION
KEPHAZON-S 1g
Each vial contains:
Sulbactam Sodium USP eq. to Sulbactam……….0.5 g
Cefoperazone Sodium USP eq. to Cefoperazone…….0.5 g
KEPHAZON-S 2g
Each vial contains :
Sulbactam Sodium USP eq. to Sulbactam………..1.0 g
Cefoperazone Sodium USP eq. to Cefoperazone……..1.0 g

⛨ Alendronic acid + Cholecalciferol⚕️BONICENTINDICATIONAlendronic acid + Cholecalciferol is indicated for the treatment ...
01/08/2024

⛨ Alendronic acid + Cholecalciferol
⚕️BONICENT

INDICATION
Alendronic acid + Cholecalciferol is indicated for the treatment of post-menopausal osteoporosis in women who are not receiving vitamin D supplementation and are risk of vitamin D insufficiency.
Alendronic acid + Cholecalciferol reduces the risk of vertebral and hip fractures.

DOSAGE AND METHOD OF ADMINISTRATION
Dosage:
The recommended dose is one Alendronic acid + Cholecalciferol tablet once weekly.
Patients should be instructed that if they miss a dose of Alendronic acid + Cholecalciferol, they should take one tablet in the morning after they remember.
They should not take two tablets on the same day but should return to taking one tablet once a week, as originally scheduled on their chosen day.

Due to the nature of the disease process in osteoporosis, Alendronic acid + Cholecalciferol is intended for long term use. The optimal duration of bisphosphonate treatment for osteoporosis has not been established. The need for continued treatment should be re-evaluated periodically based on the benefits and potential risks of Alendronic acid + Cholecalciferol in an individual patient basis, particularly after 5 or more years of use.

Patients should receive supplemental calcium if intake from diet is inadequate. The equivalence of intake of 5,600 I.U. of vitamin D. weekly in Alendronic acid + Cholecalciferol to daily dosing of vitamin D 800 I.U. has not been studied.

Elderly population:
In clinical studies, there was no age-related difference in the efficacy or safety profiles of alendronate. Therefore, no dose adjustment is necessary for the elderly.

Renal impairment:
Alendronic acid + Cholecalciferol is not recommended for patients with renal impairment where glomerular filtration rate (GFR) is less than 35 mL/min, due to lack of experience. No dose adjustment is necessary for patients with a GFR greater than 35 mL/min.

Pediatric population:
The safety and efficacy of Alendronic acid + Cholecalciferol in children less than 18 years of age has not been established. Alendronic acid + Cholecalciferol should not be used in children less than 18 years of age because no date are available.

FORMULATION
Each tablet contains:
Alendronic acid
(as Alendronate Sodium Trihydrate), BP………..70 mg
Cholecalciferol (Vitamin D,), EP………………..5,600 I.U.

Address

Minglanilla

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Central West Medicale Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Central West Medicale Inc.:

Shortcuts

Share

Category

Our History

Central West Medicale Inc. was founded on July 10, 2010, with a commitment to be a healthcare partner that provides access to medicines that are safe, effective, and affordable and to give the public an advance medical benefit.

As years passed by through its perseverance and hard work, Central West Medicale Inc. is proud and privileged to have 20 exclusive brands. Our exclusive brand has their own sales force division that will channel our medicines base on the need of the healthcare provider namely;

Cardiology deals with disorders of the heart as well as some parts of the circulatory system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology.

COVID Essentials – a division that carries anti covid essentials which includes Air Purifier, UV Light Sterilizer and Disinfectants.